期刊文献+

胸部创伤合并心功能和心肌细胞损害的早期监测与临床观察 被引量:1

The early detection and clinical observation of chest trauma combined cardiac function and myocardial cell damage
下载PDF
导出
摘要 目的:探讨血清N末端B型钠尿肽原(NT-proBNP)和心脏型脂肪酸结合蛋白(h-FABP)在胸部创伤所致心肌挫伤的早期监测价值,并观察重组人生长激素(rhGH)的治疗效果。方法:选择82例胸部创伤合并心肌挫伤患者(挫伤组)和50例健康人(对照组)为研究对象,挫伤组采用rhGH治疗。血清NT-proBNP检测采用电化学发光免疫分析(ECLIA)法,血清h-FABP检测采用双抗体夹心酶联免疫(ELISA)一步法。结果:治疗前血清h-FABP阳性率(41.4%)显著高于NT-proBNP(29.8%)及心电图(ECG)(17.7%)(P<0.01)。治疗前,胸部创伤合并心肌挫伤患者血清NT-proBNP和h-FABP水平分别与对照组比较差异有统计学意义(P<0.01);治疗后,两者水平均显著低于治疗前(P<0.01),与对照组比较,差异无统计学意义(P>0.05)。胸部创伤合并心肌挫伤患者血清NT-proBNP与h-FABP呈显著正相关(r=0.719,P<0.01),相关性良好。胸部创伤合并心肌挫伤的82例患者经rhGH治疗后,血清NT-proBNP和h-FABP水平达正常,ECG也无异常表现,无一例死亡病例。结论:rhGH对胸部创伤合并心肌挫伤具有临床治疗作用,血清NT-proBNP和h-FABP的联合检测可早期诊断胸部创伤合并心功能及心肌细胞损害,也可观察临床疗效。 Objective:Through the observation of chest trauma caused by myocardial contusion patients serum N - termi- nal pro - B - type natriuretic peptide ( NT - proBNP) and heart - type fatty acid binding protein ( h - FABP) level change, discuss the merger to early cardiac function and myocardial cell damage monitoring value, to observe the clinical efficacy of re- combinant human growth hormone (rhGH) treatment. Methods : A total of 82 patients with chest trauma combined with myocar- dial contusion (contusion group) and cases of control group as the research object, contusion group using rhGH treatment. Ser- um NT - proBNP detection using electrochemiluminescence immunoassay ( ECLIA ) method, serum h - FABP detection using enzyme- linked immunosorbent assay (ELISA) method. Results:Before treatment serum h - FABP positive rate (41.4%) was statistically higher than NT - proBNP (29.8%) and ECG ( 17.7% ) ( P 〈 0.01 ). Before treatment NT - proBNP and h - FABP were significantly higher than those in the control group(P 〈 0.01 ). After treatment level significantly (P 〈 0.01 ), and the control group there was no significant difference in sex( P 〉 0. 05 ). Serum NT- proBNP and h -FABP is a significant posi- tive correlation( r =0. 719, P 〈 0.01 ), and the correlation is good. 82 patients after treatment by rhGH, serum NT -proBNP and h - FABP level of normal, ECG and no abnormality, no 1 deaths. Conclusion: rhGH chest trauma to merge myocardial con- tusion therapeutic effect, combined detection of serum NT - proBNP and h - FABP level and can be early diagnosis chest trau- ma combined cardiac function and myocardial cell damage, and clinical curative effect observation.
作者 洪生 杨文东
出处 《临床医药实践》 2014年第5期334-337,共4页 Proceeding of Clinical Medicine
关键词 胸部创伤 N末端B型钠尿肽原 心脏型脂肪酸结合蛋白 重组人生长激素 早期诊断 临床疗效 chest trauma N - terminal pro - B - type natriuretic peptide heart - type fatty acid binding protein recom- binant human growth hormone early diagnosis clinical curative effect
  • 相关文献

参考文献14

二级参考文献84

共引文献139

同被引文献18

  • 1Chakraborty S, Geetha M, Dessai S, et al. How well do elderly pa- tients with cervical cancer tolerate definitive radioehemotherapy u- sing RapidArc? Results from an institutional audit comparing elder- ly versus younger patients [ J ]. Ecancermedicalscienee, 2014, 11 (8) :484.
  • 2Liu Z, Tian Z, Zhang C, et al. Mierovaseular reconstruction in elder- ly oral cancer patients : Does diabetes status have a predictive role in free flap complications [ J] ? J Oral Maxillofae Surg, 2014, 8 (14) :1316 -1320.
  • 3Assimakopoulos SF, Tsamandas AC, Louvros E, et al. Intestinal epi- thelial cell proliferation apoptosis and expression of tight junction proteins in patients with obstructive jaundice [ J ]. Eur J Clin In- vest,2011,41 (2) :117 - 125.
  • 4Nazia Rashid, Paul Saenger, Wu YL, et al. Erratum to : Switching to omnitropefrom other recombinant human growth hormone therapies: A retrospective study in an integrated healthcare system[ J]. Biol T- her,2014,11 (4) :81.
  • 5Htiybye C, Savendahl L, Christesen HT, et al. The NordiNet In- ternational Outcome Study and NovoNet ANSWER Program : rationale, design, and methodology of two international pharmacoep- idemiological registry - based studies monitoring long - term clini- cal and safety outcomes of growth hormone therapy ( Norditropin) [ J]. Clin Epidemio1,2013,4 (26) : 119 - 127.
  • 6SA Jones, R Parini, P Harmatz, et al. The effect of idursulfase on growth in patients with Hunter syndrome : data from the Hunter Out- come Survey ( HOS ) [ J ]. Mol Genet Metab, 2013,5 ( 37 ) : 447 - 454.
  • 7McKie PM, Cataliotti A, Lahr BD, et al. The prognostic value of N - terminal pro - B - type natriuretic peptide for death and cardio- vascular events in healthy normal and stage AZB heart failure sub- jects [ J ]. Am Coil Cardio ,2010,55 ( 19 ) :2140 - 2147.
  • 8Gurkan Kiran A, Harnn Ciralik, Davut Ozbag, et al. Comparison of transforming growth factor bl concentrations in the ovaries of rats stimulated by human menopausal gonadotropin or recombinant folli- cle - stimulating hormone [ J ]. Eur J Obst Gynecol Reproductive Biol,2012,7 ( 163 ) :35 - 38.
  • 9C6zares - Delgadillo, Ganem - Rondero, Kalia. Human growth hor- mone : new delivery systems, alternative routes of administration, and their pharmacological relevance [ J ]. Eur Pharm Biopharm, 2011,78(2) :278 -288.
  • 10Ren T, Yuan W, Zhao H, et al. Sustained - release polylactide - co- glycolide microspheres loaded with pre -formulated protein polysaccharide nanoparticles [ J ]. Micro Nano Lett, 2011,3 ( 6 ) : 70 - 74.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部